PAPER Chipika RH, Siah WF, Shing SL, Finegan E, McKenna MC, Christidi F, Chang KM, Karavasilis E, Vajda A, Hengeveld JC, Doherty MA, Donaghy C, Hutchinson S, McLaughlin RL, Hardiman O, Bede P
SEARCH RESULTS
18311 RESULTS
PAPER Beers DR, Zhao W, Neal DW, Thonhoff JR, Thome AD, Faridar A, Wen S, Wang J, Appel SH
Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosis.
Sci Rep. 2020 Sep 17;10(1):15295. PubMed: 32943739PAPER Forsberg Morén A, Varrone A
Timing is everything: tau imaging across stages of Alzheimer's disease.
Brain. 2020 Sep 1;143(9):2634-2636. PubMed: 32947616PAPER Zhao A, Li Y, Deng Y, Alzheimer’s Disease Neuroimaging Initiative
TNF receptors are associated with tau pathology and conversion to Alzheimer's dementia in subjects with mild cognitive impairment.
Neurosci Lett. 2020 Nov 1;738:135392. Epub 2020 Sep 15 PubMed: 32947003PAPER Francesco DL, Koch G
Synaptic impairment: The new battlefield of Alzheimer's disease.
Alzheimers Dement. 2021 Feb;17(2):314-315. Epub 2020 Sep 18 PubMed: 32946657PAPER Huang Y, Jianfang M, Morales R, Tang H
Corticobasal manifestations of Creutzfeldt-Jakob disease with D178N-homozygous 129M genotype.
Prion. 2020 Dec;14(1):232-237. PubMed: 32946318PAPER Quan Q, Li X, Feng J, Hou J, Li M, Zhang B
Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
Mol Med Rep. 2020 Oct;22(4):3277-3288. Epub 2020 Aug 7 PubMed: 32945455PAPER Pedroso RV, Fraga FJ, Pavarini SC, Nascimento CM, Ayán C, Cominetti MR
A Systematic Review of Altered P300 Event-Related Potential in Apolipoprotein E4 (APOE4) Carriers.
Clin EEG Neurosci. 2020 Sep 18;:1550059420959966. PubMed: 32945192PAPER Lao PJ, Gutierrez J, Keator D, Rizvi B, Banerjee A, Igwe KC, Laing KK, Sathishkumar M, Moni F, Andrews H, Krinsky-McHale S, Head E, Lee JH, Lai F, Yassa MA, Rosas HD, Silverman W, Lott IT, Schupf N, Brickman AM
Alzheimer-Related Cerebrovascular Disease in Down Syndrome.
Ann Neurol. 2020 Dec;88(6):1165-1177. Epub 2020 Oct 9 PubMed: 32944999PAPER Huang C, Wen C, Yang M, Li A, Fan C, Gan D, Li Q, Zhao J, Zhu L, Lu D
Astaxanthin Improved the Cognitive Deficits in APP/PS1 Transgenic Mice Via Selective Activation of mTOR.
J Neuroimmune Pharmacol. 2020 Sep 18; PubMed: 32944864PAPER Chen YY, Wang MC, Wang YN, Hu HH, Liu QQ, Liu HJ, Zhao YY
Redox signaling and Alzheimer's disease: from pathomechanism insights to biomarker discovery and therapy strategy.
Biomark Res. 2020;8:42. Epub 2020 Sep 11 PubMed: 32944245PAPER Chidambaram H, Das R, Chinnathambi S
Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation.
Cell Biosci. 2020;10:109. Epub 2020 Sep 15 PubMed: 32944223PAPER Gabr M, Rehman AU, Chen HF
Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling.
ACS Med Chem Lett. 2020 Sep 10;11(9):1759-1765. Epub 2020 Aug 11 PubMed: 32944144PAPER Schrauf RW
Epistemic Responsibility- Labored, Loosened, and Lost: Staging Alzheimer's Disease.
J Pragmat. 2020 Oct;168:56-68. Epub 2020 Aug 1 PubMed: 32943809PAPER Villoslada P, Baeza-Yates R, Masdeu JC
Author Correction: Reclassifying neurodegenerative diseases.
Nat Biomed Eng. 2020 Dec;4(12):1221. PubMed: 32943770Current Filters
- Date Range : Sep 2019 to Sep 2020 x